期刊文献+

系统性红斑狼疮血清可溶性诱骗受体3高表达的临床相关性初探 被引量:2

原文传递
导出
摘要 系统性红斑狼疮(systemic lupus erythematosus,SLE)是免疫器官损伤的自身免疫性疾病,普通人群中的发病率为0.05%,且80%。90%为女性,发病机制不明,但SLE包括凋亡缺陷导致的自身反应免疫异常。
出处 《中华风湿病学杂志》 CAS CSCD 北大核心 2009年第9期650-651,共2页 Chinese Journal of Rheumatology
基金 浙江省医学重点学科基金(07-010)
  • 相关文献

参考文献9

  • 1Costenbader KH, Feskanich D, Stampfer MJ, et al. Reproductive and menopausal factors and risk of systemic lupus erythematosus in women. Arthritis Rtheum, 2007, 56: 1251-1262.
  • 2Pitti RM, Marsters SA, Lawrence DA, et al. Genomic amplification of a decory receptor for Fas ligand in lung and colon cancer. Nature, 1998, 396: 699-703.
  • 3Jodo S, Kobayashi S, Kayagaki N, et al. Serum levels of soluble Fas/APO-1 (CD95) and its molecular structure in patients with systemic lupus erythematosus (SLE) and other autoimmune diseases. Clin Exp Immuuol, 1997, 107: 89-95.
  • 4Otsuki T, Tomokuni A, Sakaguchi H, et al. Over-expression of the decoy receptor 3 (DcR3) gene in peripheral blood mononuclear cells (PBMC) derived from silicosis patients. Clin Exp Immunol, 2000, 119: 323-327.
  • 5Bombardier C, Gladman DD, Urowitz MB, et al. The Committee Prognosis studies in SLE derivation of the SLEDSAI: a disease activity index for lupus patients. Arthrits'Rheum, 1992, 35: 630- 640.
  • 6Bing H, Rafael B, Luis M, et al. DcR3 as a diagnostic parameter and risk factor for systemic lupus erythematosus. Int Immunol, 2005, 20: 1067-1075.
  • 7Lee GS, Hu GY, Tsai HF, et al. Elevated serum decoy receptor 3 with enhanced T cell activation in systemic lupus erythematosus. Clin Exp Immunol, 2008, 151: 383-390.
  • 8Wu YL, Hart B, Sheng H, et al. Clinical significance of detecting elevated serum DcR3/TR6/M68 in malignant tumor patients. Cancer, 2003, 105: 724-732.
  • 9Guixiu S, Jianning M, Guang Y, et al. Tumor vaccine based on cell surface expression of DcR3/TR6. J Immunol, 2005, 174: 4727-4735.

同被引文献16

  • 1Pitti RM,Marsters SA,Lawrence DA,et al.Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer.Nature,1998,396(6712):699-703.
  • 2Hayashi S,Miura Y,Nishiyama T,et al.Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis.Arthritis Rheum,2007,56 (4):1067-1075.
  • 3Lee CS,Hu CY,Tsai HF,et al.Elevated serum decoy receptor 3 with enhanced T cell activation in systemic lupus erythematosus.Clin Exp hnmunol,2008,151(3):383-390.
  • 4Wan X,Shi G,Semenuk M,et al.DcR3/TR6 modulates immune cell interactions.J Cell Biochem,2003,89(3):603-612.
  • 5VitaliC,PalombiG,BaldiniC,et al.Sj(o)gren's syndrome disease damage index and disease activity index:scoring systems for the assessment of disease damage and disease activity in Sj(o)gren's syndrome,derived from an analysis of a cohort of Italian patients.Arthritis Rheum,2007,56(7):2223-2231.
  • 6Fayad R,Brand MI,Stone D,et al.Apoptosis resistance in ulcerative colitis:high expression of decoy receptors by lamina propria T cells.Eur J Immunol,2006,36(8):2215-2222.
  • 7Costenbader KH, Feskanich D, Stampfer M J, et al. Reproductive and menopausal factors and risk of systemic lupus erythematosus in Women [ J]. Arthritis Rheum, 2007, 56(4) : 1251 -1262.
  • 8Pittl RM, Marsters SA, Lawrence DA, et al. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer[J]. Nature, 1998, 396(6712) : 699 -703.
  • 9Yu KY, Kwon B, Ni J, et al. A newly identified member of tumor necrosis factor receptor superfamily( TR6 ) suppresses LIGHT- media- ted apoptosis[ J]. J Biol Chem, 1999, 274(20) : 13733 -13736.
  • 10Bombardier C, Gladman DD, Urowitz MB, et al. The Committee Prog- nosis studies in SLE derivation of the SLEDAI : a disease activity index for lupus patients [ J ]. Arthritis Rheum, 1992, 35 (6) : 630 - 640.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部